HPV — United States

Routine vaccination at 11 or 12, catch-up to 26, and screening that now allows self-collection.

Illustration: HPV — United States

The legal framework

Vaccination is recommended routinely at 11 or 12, with catch-up to 26 and shared decision-making between 27 and 45. Coverage varies widely by state because there is no national school programme. Cervical screening combines cytology and HPV testing depending on age, and self-collection of samples in healthcare settings was authorised in 2024, an important step for people who avoid pelvic examinations.

Key points

Routine age11 or 12, with vaccination possible from 9
Catch-upRecommended to 26; shared decision-making from 27 to 45
CoverageVaries widely by state; there is no national school programme
Vaccines for ChildrenProvides free vaccine for eligible uninsured and underinsured children
Screening 21-29Cytology every three years
Screening 30-65HPV testing or co-testing every five years, or cytology every three
Self-collectionAuthorised in 2024 for use in healthcare settings

In practice

Cost and coverage

Most insurance must cover vaccination and screening without cost sharing; free programmes exist for uninsured children.

Recent changes

Authorisation of self-collection in 2024 opened screening to people who had avoided it because of the examination itself.

Where to go

Worth knowing

Because there is no national school programme, coverage depends heavily on where you live and on your insurance. Do not assume the vaccine will be offered — ask for it.

Official sources and links

← All countries HPV →

Page checked in September 2026. The instruments cited can change: if in doubt, confirm with the official source given.

Locate this page in the site map

A question, a correction, a suggestion? Write to us.